IDiyas

For the Inventor, By the Inventor

Daejeon, South Korea

Ji Hyun Park

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Yuseong-gu, KR (2014)
  • Gyeonsangnam-do, KR (2014)
  • Gyeongsangnam-do, KR (2012 - 2015)
  • Daejeon, KR (2011 - 2021)

Company Filing History:

goldMedal7 out of 321 
 
Korea Research Institute of Bioscience and Biotechnology
 patents
silverMedal4 out of 8,305 
 
Lg Chem, Ltd
 patents
bronzeMedal2 out of 167 
 
Hankook Tire Co., Ltd.
 patents
4. 1 out of 1,238 
 
Sungkyunkwan University
 patents
5. 1 out of 2,607 
 
Korea Advanced Institute of Science and Technology
 patents
6. 1 out of 17 
 
Immunomet Therapeutics Inc.
 patents
7. 1 out of 4 
 
Industry-academic Cooperation Foundation, the Catholic University of Korea
 patents
8. 1 out of 97 
 
Hanwha Chemical Corporation
 patents
where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 12441877 - Thermoplastic resin composition (2025-10-14),
2. 12441830 - Method for preparing polyolefin-polystyrene-based multiblock copolymer (2025-10-14),
3. 12122905 - Polyolefin-polystyrene multi-block copolymer and method for producing same (2024-10-22),
4. 12116445 - Polyolefin-polystyrene multi-block copolymer and method for producing same (2024-10-15),
5. 10982076 - Rubber composition for tire tread and tire manufactured using same (2021-04-20),
6. 10780741 - Rubber composition for tire treads and tire manufactured by using the same (2020-09-22),
7. 10221190 - Biguanide compounds and use thereof (2019-03-05),
8. 9617304 - Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer (2017-04-11),
9. 9200058 - Dual antagonist for TNF-α and IL-21 for preventing and treating autoimmune diseases (2015-12-01),
10. 8993343 - CD93 or use of soluble fragment thereof (2015-03-31),
11. 8785392 - Method for inhibiting cancer metastasis by administration of the extracellular domain DLK1 or a DLK1-FC fusion protein (2014-07-22),
12. 8778901 - Anticancer drug comprising inhibitor of TMPRSS4 (2014-07-15),
13. 8715670 - Human monoclonal antibody that specifically binds to VCAM-1 and a composition for treating an inflammatory disease or a cancer comprising the same (2014-05-06),
14. 8501175 - TMPRSS4-specific human antibody (2013-08-06),
15. 8197809 - CD9-specific human antibodies (2012-06-12),

Title: The Innovative Journey of Inventor Ji Hyun Park

Introduction: Ji Hyun Park is a visionary inventor based in Daejeon, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ji Hyun Park holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to pushing the boundaries of what is possible in the modern world.

Career Highlights: With a career spanning over two decades, Ji Hyun Park has worked tirelessly to bring his ideas to life, leading to the development of cutting-edge solutions that have revolutionized industries and improved the lives of many.

Collaborations: Throughout his career, Ji Hyun Park has collaborated with leading research institutions, universities, and tech companies to further his research and bring his inventions to the market. His collaborative spirit has been instrumental in the success of many projects.

Conclusion: Ji Hyun Park's passion for innovation and his dedication to creating a better future through technology make him a true pioneer in the world of inventions. His work continues to inspire and shape the landscape of innovation for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…